Literature DB >> 17030854

Parvoviral nuclear import: bypassing the host nuclear-transport machinery.

Sarah Cohen1, Ali R Behzad1, Jeffrey B Carroll1, Nelly Panté1.   

Abstract

The parvovirus Minute virus of mice (MVM) is a small DNA virus that replicates in the nucleus of its host cells. However, very little is known about the mechanisms underlying parvovirus' nuclear import. Recently, it was found that microinjection of MVM into the cytoplasm of Xenopus oocytes causes damage to the nuclear envelope (NE), suggesting that the nuclear-import mechanism of MVM involves disruption of the NE and import through the resulting breaks. Here, fluorescence microscopy and electron microscopy were used to examine the effect of MVM on host-cell nuclear structure during infection of mouse fibroblast cells. It was found that MVM caused dramatic changes in nuclear shape and morphology, alterations of nuclear lamin immunostaining and breaks in the NE of infected cells. Thus, it seems that the unusual nuclear-import mechanism observed in Xenopus oocytes is in fact used by MVM during infection of host cells.

Entities:  

Mesh:

Year:  2006        PMID: 17030854     DOI: 10.1099/vir.0.82232-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  30 in total

1.  Simian virus 40 induces lamin A/C fluctuations and nuclear envelope deformation during cell entry.

Authors:  Veronika Butin-Israeli; Orly Ben-nun-Shaul; Idit Kopatz; Stephen A Adam; Takeshi Shimi; Robert D Goldman; Ariella Oppenheim
Journal:  Nucleus       Date:  2011-07-01       Impact factor: 4.197

2.  Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus.

Authors:  Sarah C Nicolson; R Jude Samulski
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

3.  Parvovirus Capsid Structures Required for Infection: Mutations Controlling Receptor Recognition and Protease Cleavages.

Authors:  Heather M Callaway; Kurtis H Feng; Donald W Lee; Andrew B Allison; Melissa Pinard; Robert McKenna; Mavis Agbandje-McKenna; Susan Hafenstein; Colin R Parrish
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

4.  Nuclear envelope disruption involving host caspases plays a role in the parvovirus replication cycle.

Authors:  Sarah Cohen; Alexandra K Marr; Pierre Garcin; Nelly Panté
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

5.  Characterization of the early steps of human parvovirus B19 infection.

Authors:  Silva Quattrocchi; Nico Ruprecht; Claudia Bönsch; Sven Bieli; Christoph Zürcher; Klaus Boller; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

6.  Impact of VP1-specific protein sequence motifs on adeno-associated virus type 2 intracellular trafficking and nuclear entry.

Authors:  Ruth Popa-Wagner; Manvi Porwal; Michael Kann; Matthias Reuss; Marc Weimer; Luise Florin; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

7.  Adeno-associated virus capsid proteins may play a role in transcription and second-strand synthesis of recombinant genomes.

Authors:  Maxim Salganik; Fikret Aydemir; Hyun-Joo Nam; Robert McKenna; Mavis Agbandje-McKenna; Nicholas Muzyczka
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

Review 8.  Strategies on the nuclear-targeted delivery of genes.

Authors:  Jing Yao; Ying Fan; Yuanke Li; Leaf Huang
Journal:  J Drug Target       Date:  2013-08-22       Impact factor: 5.121

9.  Densovirus infectious pathway requires clathrin-mediated endocytosis followed by trafficking to the nucleus.

Authors:  Agnès Vendeville; Marc Ravallec; Françoise-Xavière Jousset; Micheline Devise; Doriane Mutuel; Miguel López-Ferber; Philippe Fournier; Thierry Dupressoir; Mylène Ogliastro
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

10.  Parvovirus particles and movement in the cellular cytoplasm and effects of the cytoskeleton.

Authors:  Sangbom Michael Lyi; Min Jie Alvin Tan; Colin R Parrish
Journal:  Virology       Date:  2014-04-25       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.